Al-Razi Medical Company (TADAWUL:9572)

Saudi Arabia · Delayed Price · Currency is SAR

26.70

-0.22 (-0.82%)

Aug 13, 2026, 2:07 PM AST

Al-Razi Medical Company Financials Overview

Financials in millions SAR. Fiscal year is January - December.

Millions SAR. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	76.4	74.38	61.35	61.33	52.39	45.19
Revenue Growth	2.71%	21.24%	0.03%	17.07%	15.95%	-
Gross Profit	19.77	19.14	16.4	17.3	15.97	12.95
Operating Income	1.66	1.52	0.38	1.55	2.57	2.42
Net Income	1.12	0.82	0.18	0.69	2.01	2.16
Earnings Per Share	0.74	0.54	0.12	0.45	1.33	1.42
EPS Growth	36.97%	365.96%	-74.36%	-65.95%	-6.87%	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	0.29	0.31	0.77	0.85	1.53	7.79
Total Debt	10.84	11.92	8.64	10.69	7.62	6.58
Net Cash (Debt)	-10.54	-11.61	-7.87	-9.84	-6.09	1.21
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-6.94	-7.64	-5.18	-6.47	-4.01	0.79

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	6.14	5.82	4.96	5.78	2.05	-1.71
Capital Expenditures	-1.87	-1.97	-3.86	-4.78	-2.69	-1.11
Free Cash Flow	4.27	3.85	1.1	1	-0.64	-2.82
Free Cash Flow Growth	10.96%	249.88%	10.32%	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	25.88%	25.73%	26.73%	28.21%	30.49%	28.67%
Operating Margin	2.18%	2.04%	0.62%	2.54%	4.91%	5.36%
Pretax Margin	1.75%	1.44%	0.86%	1.77%	4.63%	5.61%
Profit Margin	1.47%	1.10%	0.29%	1.12%	3.84%	4.79%
FCF Margin	5.59%	5.17%	1.79%	1.63%	-1.22%	-6.25%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Aug '26 Aug 17, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Dividend Per Share	1.587	-	-	1.587
Dividend Per Share Growth	-	-	-	-
Dividend Yield	5.94%	-	-	2.65%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 17, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	36.97	56.57	509.93	132.51	-	-
P/FCF Ratio	9.72	12.05	81.55	91.19	-	-
PS Ratio	0.54	0.62	1.46	1.48	-	-